Multimedia |
CME From JCP |
JCP Supplement |
CME From PCC
MultimediaAfter so many years of having inadequate treatment options, you can finally offer patients with tardive dyskinesia approved medications that reduce symptoms. Follow along as expert Dr Leslie Citrome reviews the evidence. [top]
Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment
Medication Options and Clinical Strategies for Treating Tardive Dyskinesia
Leslie L. Citrome, MD, MPH
[Activity] [Posttest] 1/31/2022
Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools
Stephen R. Saklad, PharmD, BCPP
[Activity] [Posttest] 12/31/2021
Strategies for Acute and Maintenance Treatment of Bipolar I Disorder
Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder
Trisha Suppes, MD, PhD
[Activity] [Posttest] 12/31/2021
Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder
Trisha Suppes, MD, PhD
[Activity] [Posttest] 12/31/2021
Earlier Diagnosis and Expanded Treatment Options for Patients With Parkinson Disease
Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease
Stuart H. Isaacson, MD
[Activity] [Posttest] 12/31/2021
Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments
Stuart H. Isaacson, MD
[Activity] [Posttest] 12/31/2021
Early Recognition and Treatment of Tardive Dyskinesia in Patients with Mood Disorders and Schizophrenia
Treatment Strategies for Tardive Dyskinesia
Daniel E. Kremens, MD, JD
[Activity] [Posttest] 11/30/2021
Earlier Diagnosis of Tardive Dyskinesia
Daniel E. Kremens, MD, JD
[Activity] [Posttest] 11/30/2021
FDA-Approved Medications to Treat Tardive Dyskinesia
Joseph P. McEvoy, MD
[Activity] [Posttest] 11/30/2021
Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia
Joseph P. McEvoy, MD
[Activity] [Posttest] 10/31/2021
A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease
A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease
Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD
[Activity] [Posttest] 8/31/2021
Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation
Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD
[Activity] [Posttest] 6/30/2021
Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication
Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD
[Activity] [Posttest] 2/28/2021
New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder
New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder
Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD
[Activity] [Posttest] 7/31/2021
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia
Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia
John Lauriello, MD and Diana O. Perkins, MD
[Activity] [Posttest] 3/31/2021
Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder
Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents
Melissa P. DelBello, MD, MS
[Activity] [Posttest] 12/31/2020
Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients
Manpreet K. Singh, MD, MS
[Activity] [Posttest] 12/31/2020
Current and Emerging Treatments to Address Unmet Needs in MDD
Current and Emerging Treatments to Address Unmet Needs in MDD
Michael E. Thase, MD
[Activity] [Posttest] 12/31/2020
Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder
Diagnosing Bipolar Disorder in Pediatric Patients
Kiki D. Chang, MD
[Activity] [Posttest] 1/31/2021
Treating Bipolar Disorder in Adolescents
Robert L. Findling, MD, MBA
[Activity] [Posttest] 1/31/2020
Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management
Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management
Larry Culpepper, MD, MPH (Chair); Raymond W. Lam, MD, FRCPC; and Roger S. McIntyre, MD, FRCPC
[Activity] [Posttest] 1/31/2020
Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment
Larry Culpepper, MD, MPH
[Activity] [Posttest] 10/31/2020
Impact of Cognitive Impairment on Functioning in Patients With Depression
Raymond W. Lam, MD, FRCPC
[Activity] [Posttest] 8/31/2020
Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder
Roger S. McIntyre, MD, FRCPC
[Activity] [Posttest] 8/31/2020
Emerging Treatment Strategies for Patients With Tardive Dyskinesia
Assessing Patients for Tardive Dyskinesia
John M. Kane, MD
[Activity] [Posttest] 8/31/2020
Comparing Treatments for Tardive Dyskinesia
Leslie L. Citrome, MD, MPH
[Activity] [Posttest] 8/31/2020
Epidemiology and Prevention of Tardive Dyskinesia
Christoph U. Correll, MD
[Activity] [Posttest] 7/31/2020